Examkin

Question

Difficulty: HardMenstrual Cycle Abnormalities and Contraception

A 30-year-old female presents to the outpatient clinic reporting the cessation of her menstrual cycles over the last 7 months. She previously experienced predictable 28-day intervals. Recently, she has been troubled by nighttime awakenings associated with intense sweating and flushing. She is sexually active with a single male partner and relies on barrier contraception. Medical history is noncontributory, and she takes no daily medications. Her body mass index is 22 kg/m 2^2. Vital signs are temperature 37.0°C (98.6°F), blood pressure 112/74 mm Hg, pulse 76/min, and respirations 14/min. Pelvic examination demonstrates pale, thinned vaginal epithelium with minimal secretions. The uterus is normal in size and non-tender, with no adnexal masses appreciated. A point-of-care urine pregnancy test is negative.

Arrange the following diagnostic and management steps in the most appropriate clinical sequence to evaluate and treat this patient's condition.

  1. 1Measure initial serum follicle-stimulating hormone (FSH), prolactin, and thyroid-stimulating hormone (TSH) levels
  2. 2Confirm the diagnosis with a repeat serum follicle-stimulating hormone (FSH) level drawn at least 4 weeks later
  3. 3Screen for associated autoimmune endocrinopathies (e.g., 21-hydroxylase antibodies)
  4. 4Initiate systemic estrogen and progestin therapy

Answer

The correct sequence is: (1) Initial measurement of FSH, TSH, and prolactin; (2) Confirmation with a repeat FSH level after 4 weeks; (3) Screening for associated autoimmune conditions; and (4) Initiation of systemic estrogen and progestin therapy.
The patient presents with secondary amenorrhea and signs of estrogen deficiency (hot flashes, vaginal atrophy) at age 30, strongly suggesting primary ovarian insufficiency (POI). The first step in evaluating secondary amenorrhea, after a negative beta-hCG, is measuring prolactin, TSH, and FSH. If FSH is elevated (indicating hypergonadotropic hypogonadism), it must be repeated at least 1 month later to formally diagnose POI. Because up to 30% of spontaneous POI cases are autoimmune, screening for associated adrenal and thyroid autoimmunity is required. Finally, to mitigate the cardiovascular and skeletal risks of premature estrogen loss, systemic estrogen with a progestin (to prevent endometrial hyperplasia) is initiated and maintained until age 50.

Step-by-Step Solution

1
Determine the initial laboratory evaluation for secondary amenorrhea after a negative pregnancy test.
Measure FSH, TSH, and prolactin.
This patient has secondary amenorrhea and vasomotor symptoms, pointing to a disruption in the hypothalamic-pituitary-ovarian axis. Initial labs isolate the defect to the ovaries (high FSH), thyroid (abnormal TSH), or pituitary (high prolactin).
2
Identify the criteria for diagnosing Primary Ovarian Insufficiency (POI).
Repeat the FSH level in 4 weeks.
An elevated FSH level suggests ovarian failure, but since spontaneous intermittent ovarian function can occur, diagnostic criteria for POI require two elevated FSH levels drawn at least 1 month apart.
3
Determine the necessary subsequent workup once POI is diagnosed.
Screen for autoimmune endocrinopathies.
POI is heavily associated with autoimmune disorders, particularly Hashimoto thyroiditis and Addison disease. Screening (e.g., anti-adrenal/21-hydroxylase antibodies, thyroid peroxidase antibodies) is standard of care.
4
Select the appropriate definitive management.
Initiate estrogen and progestin therapy.
Young women with POI face severe risks of accelerated bone loss and cardiovascular disease. Hormone replacement must be initiated (with progestin to protect the intact uterus) and continued until the natural age of menopause.

Key Concept

The evaluation of secondary amenorrhea requires ruling out pregnancy followed by FSH, TSH, and prolactin levels. Diagnosis of primary ovarian insufficiency (POI) specifically requires two elevated FSH levels at least 1 month apart, followed by autoimmune screening and initiation of hormone replacement therapy.
Estimated Time:1m 30s
Rate this question

Topics

Menstrual Cycle Abnormalities and Contraception

More questions from this topic